Dysregulated ANO1 expression promotes oncogenic progression in multiple malignancies, including breast cancer, gastric cancer, and head and neck squamous cell carcinoma (HNSCC) [77,215,216]. The gene discussed is ANO1; the disease is head and neck squamous cell carcinoma.